Repetitive hypoxia extends endogenous neurovascular protection for stroke
- 11 January 2011
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 69 (6) , 975-985
Abstract
Objective: Brief systemic hypoxia protects the rodent brain from subsequent ischemic injury, although the protection wanes within days. We hypothesized that the duration of ischemic tolerance could be extended from days to months by repeated intermittent hypoxia of varying magnitude and duration.Methods: Infarction volumes following a 60‐minute transient middle cerebral artery occlusion were determined in adult male mice 2 days through 8 weeks after completion of a 2‐week repetitive hypoxic preconditioning (RHP) protocol. Separate cohorts were studied for the protective effects of RHP on postischemic and cytokine‐induced cerebrovascular inflammation, and for potential deleterious effects of the RHP stimulus itself.Results: RHP protection against transient focal stroke persisted for 8 weeks. Leukocyte adherence to cortical venules was attenuated in response to stroke, as well as following tumor necrosis factor‐α administration, indicating that reductions in postischemic inflammation were not secondary to smaller infarct volumes. RHP reduced poststroke leukocyte diapedesis concomitant with a long‐lasting downregulation of endothelial adhesion molecule mRNAs, and also reduced postischemic blood–brain barrier permeability to endogenous immunoglobulin G. RHP was without effect on hippocampal CA1 pyramidal cell viability, only transiently elevated hematocrit, and did not affect the magnitude of cerebral blood flow during and after ischemia.Interpretation: Taken together, our findings reveal a novel form of epigenetic neurovascular plasticity characterized by a prominent anti‐inflammatory phenotype that provides protection against stroke many weeks longer than previously established windows of preconditioning‐induced tolerance. Translating these endogenous protective mechanisms into therapeutics could afford sustained periods of cerebroprotection in subpopulations of individuals at identified risk for stroke. ANN NEUROL 2011Keywords
This publication has 55 references indexed in Scilit:
- Obstructive Sleep Apnea–Hypopnea and Incident Stroke: The Sleep Heart Health StudyAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Pharmacologic Preconditioning: Translating the PromiseTranslational Stroke Research, 2010
- Molecular Magnetic Resonance Imaging of Acute Vascular Cell Adhesion Molecule-1 Expression in a Mouse Model of Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2010
- Neutrophil elastase and neurovascular injury following focal stroke and reperfusionNeurobiology of Disease, 2009
- Daily intermittent hypoxia augments spinal BDNF levels, ERK phosphorylation and respiratory long-term facilitationExperimental Neurology, 2009
- Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical useThe Lancet Neurology, 2009
- Deferroxamine Preconditioning Promotes Long-Lasting Retinal Ischemic ToleranceJournal of Ocular Pharmacology and Therapeutics, 2008
- Slit modulates cerebrovascular inflammation and mediates neuroprotection against global cerebral ischemiaExperimental Neurology, 2007
- Cerebral preconditioning and ischaemic toleranceNature Reviews Neuroscience, 2006
- Normobaric Hypoxia Induces Tolerance to Focal Permanent Cerebral Ischemia in Association with an Increased Expression of Hypoxia-Inducible Factor-1 and its Target Genes, Erythropoietin and VEGF, in the Adult Mouse BrainJournal of Cerebral Blood Flow & Metabolism, 2002